HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $838,000 | -57.7% | 146,436 | -32.5% | 0.09% | -44.3% |
| Q4 2021 | $1,982,000 | -22.3% | 217,028 | -9.1% | 0.17% | -25.8% |
| Q3 2021 | $2,552,000 | -32.8% | 238,707 | -2.5% | 0.22% | -32.2% |
| Q2 2021 | $3,800,000 | -12.2% | 244,793 | -8.3% | 0.33% | -17.6% |
| Q1 2021 | $4,327,000 | -23.3% | 266,899 | +0.2% | 0.40% | -18.9% |
| Q4 2020 | $5,639,000 | +14.1% | 266,415 | -20.1% | 0.50% | +29.1% |
| Q3 2020 | $4,943,000 | -6.9% | 333,501 | -7.7% | 0.38% | -13.7% |
| Q2 2020 | $5,312,000 | +17.3% | 361,141 | -6.4% | 0.45% | -3.9% |
| Q1 2020 | $4,528,000 | -19.7% | 385,729 | +60.7% | 0.46% | +12.1% |
| Q4 2019 | $5,640,000 | +14.7% | 240,024 | -9.7% | 0.41% | +11.9% |
| Q3 2019 | $4,917,000 | +143.8% | 265,804 | +145.0% | 0.37% | +166.2% |
| Q2 2019 | $2,017,000 | -37.2% | 108,495 | -17.4% | 0.14% | -31.9% |
| Q1 2019 | $3,210,000 | – | 131,343 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |